Concepts (309)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nursing Research | 8 | 2023 | 77 | 3.280 |
Why?
|
Hyperglycemia | 12 | 2022 | 1368 | 3.190 |
Why?
|
Neoplasms | 92 | 2024 | 21596 | 2.890 |
Why?
|
Fatigue | 39 | 2024 | 1526 | 2.860 |
Why?
|
Informed Consent | 6 | 2019 | 991 | 1.920 |
Why?
|
Antineoplastic Agents | 41 | 2024 | 13655 | 1.410 |
Why?
|
Gastrointestinal Neoplasms | 9 | 2023 | 987 | 1.280 |
Why?
|
Genital Neoplasms, Female | 5 | 2024 | 516 | 1.190 |
Why?
|
Quality of Life | 37 | 2024 | 12730 | 1.170 |
Why?
|
Biomedical Research | 6 | 2017 | 3306 | 1.150 |
Why?
|
Moral Obligations | 2 | 2017 | 96 | 1.110 |
Why?
|
Morals | 3 | 2017 | 282 | 1.080 |
Why?
|
Outpatients | 23 | 2024 | 1483 | 1.000 |
Why?
|
Blood Glucose | 7 | 2022 | 6249 | 0.940 |
Why?
|
Nursing Staff | 1 | 2022 | 129 | 0.780 |
Why?
|
Ethics, Research | 3 | 2017 | 190 | 0.760 |
Why?
|
Colonic Neoplasms | 2 | 2022 | 2542 | 0.720 |
Why?
|
Hypoglycemia | 2 | 2020 | 859 | 0.690 |
Why?
|
Nursing Process | 1 | 2019 | 16 | 0.680 |
Why?
|
Nursing Staff, Hospital | 1 | 2022 | 346 | 0.670 |
Why?
|
Ethics | 1 | 2019 | 93 | 0.670 |
Why?
|
Syndrome | 14 | 2024 | 3248 | 0.650 |
Why?
|
Nausea | 8 | 2023 | 665 | 0.610 |
Why?
|
Breast Neoplasms | 17 | 2023 | 20774 | 0.610 |
Why?
|
Data Collection | 2 | 2017 | 3339 | 0.610 |
Why?
|
Comorbidity | 16 | 2024 | 10372 | 0.560 |
Why?
|
Pain | 15 | 2024 | 4961 | 0.560 |
Why?
|
Patient Rights | 1 | 2016 | 125 | 0.520 |
Why?
|
Resilience, Psychological | 5 | 2024 | 665 | 0.520 |
Why?
|
Nurse's Role | 4 | 2023 | 209 | 0.500 |
Why?
|
Hematologic Diseases | 2 | 2016 | 498 | 0.500 |
Why?
|
Authorship | 1 | 2017 | 271 | 0.490 |
Why?
|
Humans | 158 | 2024 | 742088 | 0.490 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2019 | 5425 | 0.490 |
Why?
|
Peripheral Nervous System Diseases | 5 | 2019 | 700 | 0.470 |
Why?
|
Research Personnel | 2 | 2023 | 573 | 0.470 |
Why?
|
Exercise Therapy | 1 | 2021 | 904 | 0.470 |
Why?
|
Stress, Psychological | 15 | 2023 | 4229 | 0.460 |
Why?
|
Medical Oncology | 6 | 2024 | 2235 | 0.460 |
Why?
|
Walking | 1 | 2021 | 1177 | 0.450 |
Why?
|
Longitudinal Studies | 29 | 2024 | 13921 | 0.450 |
Why?
|
Guidelines as Topic | 2 | 2016 | 1402 | 0.440 |
Why?
|
Anxiety | 15 | 2023 | 4279 | 0.440 |
Why?
|
Confidentiality | 1 | 2017 | 609 | 0.430 |
Why?
|
Nurses | 1 | 2022 | 2459 | 0.430 |
Why?
|
Female | 96 | 2024 | 379592 | 0.430 |
Why?
|
Antiemetics | 4 | 2022 | 176 | 0.420 |
Why?
|
Adaptation, Psychological | 6 | 2023 | 2575 | 0.410 |
Why?
|
Paclitaxel | 4 | 2020 | 1707 | 0.400 |
Why?
|
Interprofessional Relations | 1 | 2017 | 1008 | 0.390 |
Why?
|
Environmental Monitoring | 1 | 2017 | 1413 | 0.380 |
Why?
|
Middle Aged | 60 | 2022 | 213127 | 0.370 |
Why?
|
Statistics as Topic | 1 | 2017 | 2372 | 0.370 |
Why?
|
Clinical Trials as Topic | 2 | 2016 | 7901 | 0.370 |
Why?
|
Patients | 6 | 2024 | 892 | 0.360 |
Why?
|
Lymphedema | 3 | 2021 | 528 | 0.360 |
Why?
|
Publishing | 1 | 2017 | 833 | 0.360 |
Why?
|
Hematologic Neoplasms | 2 | 2019 | 1820 | 0.340 |
Why?
|
Patient Selection | 2 | 2020 | 4214 | 0.330 |
Why?
|
Information Dissemination | 1 | 2017 | 1100 | 0.330 |
Why?
|
Male | 67 | 2024 | 349538 | 0.320 |
Why?
|
Societies, Nursing | 2 | 2019 | 23 | 0.320 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2022 | 11695 | 0.320 |
Why?
|
Adult | 41 | 2024 | 213712 | 0.310 |
Why?
|
Depression | 16 | 2023 | 7733 | 0.300 |
Why?
|
Factor Analysis, Statistical | 8 | 2021 | 975 | 0.290 |
Why?
|
Activities of Daily Living | 2 | 2017 | 2414 | 0.280 |
Why?
|
Circadian Rhythm | 5 | 2023 | 2623 | 0.280 |
Why?
|
Genome, Human | 1 | 2019 | 4420 | 0.260 |
Why?
|
Practice Guidelines as Topic | 3 | 2019 | 7276 | 0.260 |
Why?
|
Severity of Illness Index | 16 | 2024 | 15530 | 0.260 |
Why?
|
Photoperiod | 2 | 2015 | 136 | 0.250 |
Why?
|
Aged | 34 | 2024 | 162944 | 0.240 |
Why?
|
Genomics | 2 | 2021 | 5692 | 0.240 |
Why?
|
Research Design | 6 | 2023 | 5979 | 0.240 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2021 | 2011 | 0.240 |
Why?
|
Dyspnea | 4 | 2024 | 1298 | 0.240 |
Why?
|
Self Report | 7 | 2023 | 3548 | 0.230 |
Why?
|
Diarrhea | 2 | 2020 | 1343 | 0.220 |
Why?
|
Parents | 1 | 2016 | 3387 | 0.210 |
Why?
|
Blood Glucose Self-Monitoring | 2 | 2019 | 436 | 0.210 |
Why?
|
Cannabidiol | 1 | 2023 | 106 | 0.200 |
Why?
|
Taste | 2 | 2020 | 175 | 0.200 |
Why?
|
Cyclophosphamide | 2 | 2019 | 2236 | 0.200 |
Why?
|
Holistic Nursing | 1 | 2021 | 2 | 0.200 |
Why?
|
Evidence-Based Nursing | 1 | 2021 | 16 | 0.200 |
Why?
|
Delivery of Health Care | 2 | 2021 | 5304 | 0.200 |
Why?
|
Pediatrics | 1 | 2016 | 3462 | 0.190 |
Why?
|
Psychological Tests | 1 | 2023 | 648 | 0.190 |
Why?
|
Chronic Disease | 2 | 2015 | 9144 | 0.190 |
Why?
|
Adenosine Monophosphate | 1 | 2022 | 276 | 0.190 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2022 | 3471 | 0.190 |
Why?
|
Models, Biological | 2 | 2019 | 9581 | 0.180 |
Why?
|
Nursing Care | 1 | 2021 | 74 | 0.180 |
Why?
|
Epigenesis, Genetic | 2 | 2023 | 3639 | 0.170 |
Why?
|
DNA Methylation | 4 | 2023 | 4282 | 0.170 |
Why?
|
Aged, 80 and over | 9 | 2020 | 57683 | 0.170 |
Why?
|
Loneliness | 1 | 2021 | 184 | 0.170 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2020 | 198 | 0.170 |
Why?
|
Lung Neoplasms | 5 | 2023 | 13019 | 0.170 |
Why?
|
Job Satisfaction | 1 | 2022 | 535 | 0.160 |
Why?
|
Physical Endurance | 1 | 2020 | 370 | 0.150 |
Why?
|
Antineoplastic Agents, Phytogenic | 2 | 2019 | 623 | 0.150 |
Why?
|
Risk Factors | 18 | 2024 | 72145 | 0.150 |
Why?
|
Organizational Objectives | 1 | 2019 | 438 | 0.150 |
Why?
|
Cannabis | 1 | 2023 | 432 | 0.150 |
Why?
|
Respiration Disorders | 1 | 2020 | 370 | 0.150 |
Why?
|
Cross-Sectional Studies | 12 | 2022 | 24913 | 0.140 |
Why?
|
History, 16th Century | 1 | 2016 | 72 | 0.140 |
Why?
|
Sleep | 8 | 2023 | 4604 | 0.140 |
Why?
|
History, 17th Century | 1 | 2016 | 111 | 0.140 |
Why?
|
Forecasting | 2 | 2016 | 2948 | 0.140 |
Why?
|
Personality | 1 | 2020 | 548 | 0.140 |
Why?
|
STAT Transcription Factors | 1 | 2017 | 182 | 0.140 |
Why?
|
Fear | 2 | 2022 | 1436 | 0.140 |
Why?
|
Random Allocation | 1 | 2021 | 2425 | 0.140 |
Why?
|
History, 18th Century | 1 | 2016 | 214 | 0.140 |
Why?
|
Preventive Medicine | 1 | 2018 | 263 | 0.140 |
Why?
|
Endocytosis | 1 | 2020 | 983 | 0.130 |
Why?
|
Janus Kinases | 1 | 2017 | 244 | 0.130 |
Why?
|
Ambulatory Care | 3 | 2022 | 2706 | 0.130 |
Why?
|
Anesthetics, Inhalation | 1 | 2020 | 571 | 0.130 |
Why?
|
Periodicity | 4 | 2020 | 363 | 0.130 |
Why?
|
Ovarian Neoplasms | 2 | 2022 | 4823 | 0.130 |
Why?
|
Models, Theoretical | 1 | 2007 | 3584 | 0.120 |
Why?
|
Constipation | 1 | 2019 | 546 | 0.120 |
Why?
|
Models, Psychological | 1 | 2018 | 810 | 0.120 |
Why?
|
Cost of Illness | 2 | 2021 | 1852 | 0.120 |
Why?
|
Cluster Analysis | 4 | 2023 | 2713 | 0.120 |
Why?
|
Cognition | 5 | 2024 | 6722 | 0.120 |
Why?
|
United States | 10 | 2022 | 69693 | 0.120 |
Why?
|
Self Concept | 1 | 2020 | 1025 | 0.120 |
Why?
|
History, 19th Century | 1 | 2016 | 720 | 0.120 |
Why?
|
Perception | 1 | 2020 | 1188 | 0.120 |
Why?
|
Cytoskeleton | 1 | 2019 | 1185 | 0.120 |
Why?
|
Leadership | 1 | 2023 | 1357 | 0.110 |
Why?
|
Fasting | 1 | 2019 | 1589 | 0.110 |
Why?
|
Gene Expression Regulation | 3 | 2021 | 12071 | 0.110 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2019 | 960 | 0.110 |
Why?
|
Abdominal Pain | 1 | 2019 | 1059 | 0.110 |
Why?
|
NF-kappa B | 2 | 2022 | 2500 | 0.110 |
Why?
|
Decision Making | 2 | 2016 | 3869 | 0.110 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2017 | 719 | 0.100 |
Why?
|
Inflammasomes | 1 | 2017 | 493 | 0.100 |
Why?
|
Signal Transduction | 5 | 2022 | 23387 | 0.100 |
Why?
|
Cardiovascular Diseases | 1 | 2018 | 15108 | 0.100 |
Why?
|
Disease Outbreaks | 1 | 2021 | 1768 | 0.100 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2015 | 627 | 0.100 |
Why?
|
Congresses as Topic | 1 | 2015 | 764 | 0.090 |
Why?
|
Evidence-Based Medicine | 1 | 2022 | 3611 | 0.090 |
Why?
|
Axons | 1 | 2019 | 1681 | 0.090 |
Why?
|
Pilot Projects | 2 | 2021 | 8297 | 0.090 |
Why?
|
Prevalence | 6 | 2021 | 15194 | 0.090 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2187 | 0.090 |
Why?
|
Physician-Patient Relations | 2 | 2021 | 3215 | 0.090 |
Why?
|
History, 21st Century | 1 | 2016 | 1533 | 0.090 |
Why?
|
Prediabetic State | 1 | 2015 | 493 | 0.090 |
Why?
|
Cytokines | 3 | 2022 | 7317 | 0.090 |
Why?
|
Papillomavirus Infections | 1 | 2021 | 1585 | 0.090 |
Why?
|
Nursing Assessment | 1 | 2010 | 107 | 0.090 |
Why?
|
Patient Preference | 1 | 2016 | 886 | 0.090 |
Why?
|
Mass Screening | 3 | 2021 | 5238 | 0.090 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2021 | 3915 | 0.080 |
Why?
|
Nutrition Disorders | 1 | 2010 | 211 | 0.080 |
Why?
|
Vaginal Smears | 2 | 2021 | 511 | 0.080 |
Why?
|
History, 20th Century | 1 | 2016 | 2739 | 0.080 |
Why?
|
Health Policy | 1 | 2021 | 2657 | 0.080 |
Why?
|
Aging | 1 | 2007 | 8626 | 0.080 |
Why?
|
Hypesthesia | 2 | 2019 | 110 | 0.080 |
Why?
|
Transplantation Immunology | 1 | 2010 | 547 | 0.080 |
Why?
|
Nursing Theory | 1 | 2007 | 10 | 0.080 |
Why?
|
Gene Expression Profiling | 3 | 2021 | 9410 | 0.070 |
Why?
|
Patient Participation | 1 | 2016 | 1445 | 0.070 |
Why?
|
Quality of Health Care | 1 | 2022 | 4369 | 0.070 |
Why?
|
Sensation | 2 | 2019 | 337 | 0.070 |
Why?
|
Prescription Drugs | 1 | 2014 | 595 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2022 | 9185 | 0.070 |
Why?
|
Morbidity | 1 | 2012 | 1767 | 0.070 |
Why?
|
Acute Kidney Injury | 2 | 2016 | 1967 | 0.070 |
Why?
|
Medical History Taking | 1 | 2010 | 783 | 0.070 |
Why?
|
Complementary Therapies | 1 | 2010 | 484 | 0.070 |
Why?
|
Mitochondria | 1 | 2018 | 3520 | 0.070 |
Why?
|
Socioeconomic Factors | 4 | 2021 | 7770 | 0.070 |
Why?
|
Postoperative Complications | 2 | 2020 | 15244 | 0.070 |
Why?
|
Individuality | 2 | 2019 | 303 | 0.060 |
Why?
|
Patient-Centered Care | 3 | 2022 | 1436 | 0.060 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2020 | 3649 | 0.060 |
Why?
|
Health Status | 2 | 2016 | 4030 | 0.060 |
Why?
|
Retrospective Studies | 3 | 2022 | 77098 | 0.060 |
Why?
|
Patient Care Planning | 1 | 2010 | 921 | 0.060 |
Why?
|
Young Adult | 3 | 2022 | 56350 | 0.060 |
Why?
|
Apoptosis | 1 | 2020 | 9715 | 0.060 |
Why?
|
Body Mass Index | 2 | 2019 | 12695 | 0.060 |
Why?
|
Neoadjuvant Therapy | 1 | 2014 | 2721 | 0.060 |
Why?
|
Patient Education as Topic | 1 | 2014 | 2275 | 0.060 |
Why?
|
Communication | 3 | 2022 | 3728 | 0.060 |
Why?
|
Lymphotoxin-beta | 1 | 2022 | 12 | 0.060 |
Why?
|
National Institute of Nursing Research (U.S.) | 1 | 2022 | 3 | 0.050 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 2723 | 0.050 |
Why?
|
Qualitative Research | 2 | 2021 | 2680 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3130 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3236 | 0.050 |
Why?
|
Early Detection of Cancer | 3 | 2021 | 3070 | 0.050 |
Why?
|
Geriatric Assessment | 1 | 2010 | 1369 | 0.050 |
Why?
|
Dominican Republic | 1 | 2021 | 76 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2019 | 4440 | 0.050 |
Why?
|
Age Factors | 4 | 2021 | 18355 | 0.050 |
Why?
|
Adolescent | 4 | 2021 | 85649 | 0.050 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2022 | 2938 | 0.050 |
Why?
|
Anxiety Disorders | 2 | 2023 | 2684 | 0.050 |
Why?
|
Inflammation | 1 | 2021 | 10578 | 0.050 |
Why?
|
Gene Expression | 3 | 2020 | 7790 | 0.050 |
Why?
|
Ireland | 1 | 2021 | 160 | 0.050 |
Why?
|
Patient Discharge | 1 | 2014 | 3300 | 0.050 |
Why?
|
Pain Measurement | 2 | 2022 | 3418 | 0.050 |
Why?
|
Survivors | 2 | 2023 | 2286 | 0.050 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2022 | 281 | 0.050 |
Why?
|
Environment | 1 | 2007 | 1115 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11472 | 0.050 |
Why?
|
Exercise | 1 | 2017 | 5611 | 0.050 |
Why?
|
Prospective Studies | 2 | 2021 | 53187 | 0.050 |
Why?
|
Interpersonal Relations | 1 | 2007 | 1423 | 0.040 |
Why?
|
Vomiting | 1 | 2022 | 632 | 0.040 |
Why?
|
Germany | 1 | 2021 | 860 | 0.040 |
Why?
|
Frail Elderly | 1 | 2023 | 691 | 0.040 |
Why?
|
Emotions | 2 | 2020 | 2657 | 0.040 |
Why?
|
Quarantine | 1 | 2020 | 167 | 0.040 |
Why?
|
Social Isolation | 1 | 2021 | 363 | 0.040 |
Why?
|
Arm | 1 | 2021 | 589 | 0.040 |
Why?
|
Caribbean Region | 1 | 2018 | 194 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2017 | 15494 | 0.040 |
Why?
|
Sensory Thresholds | 1 | 2019 | 394 | 0.040 |
Why?
|
Religion | 1 | 2020 | 356 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2015 | 5724 | 0.040 |
Why?
|
Demography | 1 | 2022 | 1650 | 0.040 |
Why?
|
Electric Impedance | 1 | 2021 | 727 | 0.040 |
Why?
|
Vibration | 1 | 2019 | 325 | 0.040 |
Why?
|
Latin America | 1 | 2018 | 381 | 0.040 |
Why?
|
Uncertainty | 1 | 2021 | 725 | 0.030 |
Why?
|
California | 1 | 2020 | 1400 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2016 | 25575 | 0.030 |
Why?
|
Upper Extremity | 1 | 2021 | 648 | 0.030 |
Why?
|
Time Factors | 4 | 2019 | 40054 | 0.030 |
Why?
|
Absorptiometry, Photon | 1 | 2021 | 1726 | 0.030 |
Why?
|
Algorithms | 1 | 2016 | 13853 | 0.030 |
Why?
|
Disease Progression | 3 | 2017 | 13256 | 0.030 |
Why?
|
Hemorrhagic Disorders | 1 | 2014 | 36 | 0.030 |
Why?
|
Linear Models | 2 | 2015 | 5948 | 0.030 |
Why?
|
Infant | 1 | 2016 | 35070 | 0.030 |
Why?
|
Affect | 1 | 2022 | 1473 | 0.030 |
Why?
|
Nurse-Patient Relations | 1 | 2014 | 101 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2022 | 2502 | 0.030 |
Why?
|
Incidence | 1 | 2012 | 20928 | 0.030 |
Why?
|
Postural Balance | 1 | 2018 | 620 | 0.030 |
Why?
|
Propensity Score | 1 | 2020 | 1771 | 0.030 |
Why?
|
Child, Preschool | 1 | 2016 | 40955 | 0.030 |
Why?
|
Washington | 1 | 2014 | 313 | 0.030 |
Why?
|
Neuralgia | 1 | 2020 | 568 | 0.030 |
Why?
|
Infection Control | 1 | 2020 | 962 | 0.030 |
Why?
|
Actins | 1 | 2020 | 2120 | 0.030 |
Why?
|
Educational Status | 1 | 2020 | 2533 | 0.030 |
Why?
|
Stress, Physiological | 1 | 2020 | 1402 | 0.030 |
Why?
|
Life Change Events | 1 | 2017 | 937 | 0.030 |
Why?
|
Body Composition | 1 | 2021 | 2400 | 0.030 |
Why?
|
Weight Gain | 1 | 2022 | 2282 | 0.030 |
Why?
|
Pandemics | 2 | 2023 | 8328 | 0.030 |
Why?
|
Social Support | 1 | 2021 | 2117 | 0.020 |
Why?
|
Gastrointestinal Diseases | 1 | 2019 | 1167 | 0.020 |
Why?
|
Attention | 1 | 2021 | 2396 | 0.020 |
Why?
|
Phenotype | 2 | 2019 | 16331 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2021 | 4414 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2021 | 3278 | 0.020 |
Why?
|
Obesity, Morbid | 1 | 2020 | 1204 | 0.020 |
Why?
|
Evidence-Based Practice | 1 | 2014 | 500 | 0.020 |
Why?
|
Prefrontal Cortex | 1 | 2020 | 2146 | 0.020 |
Why?
|
Pain, Postoperative | 1 | 2019 | 1638 | 0.020 |
Why?
|
Internet | 1 | 2021 | 3062 | 0.020 |
Why?
|
Body Weight | 1 | 2019 | 4664 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2020 | 5867 | 0.020 |
Why?
|
Genetic Testing | 1 | 2021 | 3439 | 0.020 |
Why?
|
Palliative Care | 1 | 2023 | 3478 | 0.020 |
Why?
|
Child | 1 | 2016 | 77478 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2021 | 3014 | 0.020 |
Why?
|
Causality | 1 | 2014 | 1265 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2014 | 1780 | 0.020 |
Why?
|
Diabetes Complications | 1 | 2014 | 1359 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10392 | 0.020 |
Why?
|
Logistic Models | 1 | 2021 | 13403 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2014 | 1847 | 0.020 |
Why?
|
Cohort Studies | 2 | 2020 | 40450 | 0.020 |
Why?
|
Survival Analysis | 1 | 2017 | 10248 | 0.020 |
Why?
|
Graft Survival | 1 | 2014 | 3733 | 0.010 |
Why?
|
Acute Disease | 1 | 2014 | 7141 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2014 | 3081 | 0.010 |
Why?
|
Rats | 1 | 2020 | 24265 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2020 | 62966 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2020 | 10163 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2014 | 4455 | 0.010 |
Why?
|
Graft vs Host Disease | 1 | 2014 | 2951 | 0.010 |
Why?
|
Mental Health | 1 | 2016 | 2997 | 0.010 |
Why?
|
Length of Stay | 1 | 2014 | 6294 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18006 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 8425 | 0.010 |
Why?
|
Pregnancy | 1 | 2021 | 29087 | 0.010 |
Why?
|
Mental Disorders | 1 | 2019 | 6587 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2014 | 21719 | 0.010 |
Why?
|
Risk Assessment | 1 | 2017 | 23320 | 0.010 |
Why?
|
Brain | 1 | 2020 | 26343 | 0.010 |
Why?
|
Animals | 1 | 2020 | 168561 | 0.000 |
Why?
|
Concepts
(309)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(21)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_